FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Agnieszka Dejda

Research Profile

Chemicals & Drugs

Anatomy

Cerebral Cortex

Living Beings

Disorders

Neurodegenerative Diseases

Physiology

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Agnieszka Dejda; Tommy Seaborn; Steve Bourgault; Omar Touzani; Alain Fournier; Hubert Vaudry; David Vaudry
PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action.
Agnieszka Dejda; Steve Bourgault; Ngoc Duc Doan; Myriam Létourneau; Alain Couvineau; Hubert Vaudry; David Vaudry; Alain Fournier
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.
Ngoc-Duc Doan; Steve Bourgault; Agnieszka Dejda; Myriam Létourneau; Michel detheux; David Vaudry; Hubert Vaudry; David Chatenet; Alain Fournier
Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Agnieszka Dejda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Agnieszka Dejda; Tommy Seaborn; Steve Bourgault; Omar Touzani; Alain Fournier; Hubert Vaudry; David Vaudry
PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action.
Peptides 2011;32(6):1207-16.
2011: Agnieszka Dejda; Steve Bourgault; Ngoc Duc Doan; Myriam Létourneau; Alain Couvineau; Hubert Vaudry; David Vaudry; Alain Fournier
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.
Biochimie 2011;93(4):669-77.
2011: Ngoc-Duc Doan; Steve Bourgault; Agnieszka Dejda; Myriam Létourneau; Michel detheux; David Vaudry; Hubert Vaudry; David Chatenet; Alain Fournier
Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects.
Biochemical pharmacology 2011;81(4):552-61.
2010: Agnieszka Dejda; Philippe Chan; Tommy Seaborn; Laurent Coquet; THIERRY JOUENNE; Alain Fournier; Hubert Vaudry; David Vaudry
Involvement of stathmin 1 in the neurotrophic effects of PACAP in PC12 cells.
Journal of neurochemistry 2010;114(5):1498-510.
2008: Agnieszka Dejda; Valérie Jolivel; Steve Bourgault; Tommy Seaborn; Alain Fournier; Hubert Vaudry; David Vaudry
Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases.
Journal of molecular neuroscience : MN 2008;36(1-3):26-37.
2007: Olfa Masmoudi-Kouki; Pierrick Gandolfo; Hélène Castel; Jérôme Leprince; Alain Fournier; Agnieszka Dejda; Hubert Vaudry; Marie-Christine Tonon
Role of PACAP and VIP in astroglial functions.
Peptides 2007;28(9):1753-60.
2007: Marta Jozwiak-Bebenista; Agnieszka Dejda; Jerzy Z Nowak
Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices.
Pharmacological reports : PR 2007;59(4):414-20.
2006: Agnieszka Dejda; Marta Jozwiak-Bebenista; Jerzy Z Nowak
PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
Annals of the New York Academy of Sciences 2006;1070():220-5.
2005: Agnieszka Dejda; Paulina Sokołowska; Jerzy Z Nowak
Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
Pharmacological reports : PR 2005;57(3):307-20.
2005: Jolanta B Zawilska; Agnieszka Dejda; Pawel Niewiadomski; Illana Gozes; Jerzy Z Nowak
Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Journal of molecular neuroscience : MN 2005;25(3):215-24.
2004: Agnieszka Dejda; Hanna Gendek-Kubiak; Jerzy Z Nowak
Effect of different forms of vasoactive intestinal peptide on cAMP formation in the mammalian cerebral cortex.
Polish journal of pharmacology 2004;56(4):421-5.
2004: Agnieszka Dejda; Izabela Matczak; Jerzy Z Nowak
[Peptide histidine-isoleucine and and its human analogue peptide histidine-methionine: localization, receptors and biological function].
Postȩpy higieny i medycyny doświadczalnej (Online) 2004;58():18-26.
2004: Paulina Sokołowska; Agnieszka Dejda; Jerzy Z Nowak
[Neuroprotective role of PACAP, VIP, and PHI in the central nervous system].
Postȩpy higieny i medycyny doświadczalnej (Online) 2004;58():416-27.
2003: Agnieszka Dejda; Izabela Matczak; Anna Wiktorowska-Owczarek; Jerzy Z Nowak
Cyclic AMP formation in chicken brain: effect of vasoactive intestinal peptide, peptide histidine-isoleucine (PHI), and some PHI-related peptides.
Polish journal of pharmacology 2003;55(5):747-51.
2002: Agnieszka Dejda; Izabela Matczak; Wojciech A Gorczyca
p19 detected in the rat retina and pineal gland is a guanylyl cyclase-activating protein (GCAP).
Acta biochimica Polonica 2002;49(4):899-905.
2001: Jerzy Z Nowak; Agnieszka Dejda; Jolanta B Zawilska
Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex.
Polish journal of pharmacology 2001;53(6):695-9.
2001: Jerzy Z Nowak; Agnieszka Dejda; A Pigułowska; Katarzyna Kuba; Jolanta B Zawilska
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates phosphoinositide metabolism and translocation of protein kinase C in chick cerebral cortex.
Acta neurobiologiae experimentalis 2001;61(4):325.